These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 22018997

  • 21. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.
    Alberts MJ, Eikelboom JW, Hankey GJ.
    Lancet Neurol; 2012 Dec; 11(12):1066-81. PubMed ID: 23153406
    [Abstract] [Full Text] [Related]

  • 22. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
    [Abstract] [Full Text] [Related]

  • 23. New oral anticoagulants in elderly patients with atrial fibrillation.
    Deedwania PC.
    Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
    [Abstract] [Full Text] [Related]

  • 24. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
    ROCKET AF Study InvestigatorsDuke Clinical Research Institute, Durham, NC, USA..
    Am Heart J; 2010 Mar; 159(3):340-347.e1. PubMed ID: 20211293
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Atrial fibrillation and stroke].
    Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D.
    Tidsskr Nor Laegeforen; 2013 Aug 06; 133(14):1453-7. PubMed ID: 23929293
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 06; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 35. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
    Lip GY, Banerjee A, Lagrenade I, Lane DA, Taillandier S, Fauchier L.
    Circ Arrhythm Electrophysiol; 2012 Oct 06; 5(5):941-8. PubMed ID: 22923275
    [Abstract] [Full Text] [Related]

  • 36. Personalizing oral anticoagulant treatment in patients with atrial fibrillation.
    Capranzano P, Miccichè E, D'Urso L, Privitera F, Tamburino C.
    Expert Rev Cardiovasc Ther; 2013 Aug 06; 11(8):959-73. PubMed ID: 23957907
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K, Lip GY.
    Semin Thromb Hemost; 2015 Mar 06; 41(2):146-53. PubMed ID: 25682085
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.